Landscape Capital Management L.L.C. Makes New $242,000 Investment in Sabra Health Care REIT, Inc. (NASDAQ:SBRA)

Landscape Capital Management L.L.C. bought a new position in Sabra Health Care REIT, Inc. (NASDAQ:SBRA) in the third quarter, HoldingsChannel.com reports. The institutional investor bought 13,020 shares of the real estate investment trust’s stock, valued at approximately $242,000.

A number of other hedge funds have also added to or reduced their stakes in the business. Family Firm Inc. bought a new stake in shares of Sabra Health Care REIT during the second quarter valued at approximately $26,000. Assetmark Inc. increased its holdings in shares of Sabra Health Care REIT by 168.4% during the third quarter. Assetmark Inc. now owns 1,962 shares of the real estate investment trust’s stock valued at $37,000 after acquiring an additional 1,231 shares in the last quarter. GAMMA Investing LLC increased its holdings in shares of Sabra Health Care REIT by 40.0% during the second quarter. GAMMA Investing LLC now owns 3,682 shares of the real estate investment trust’s stock valued at $57,000 after acquiring an additional 1,052 shares in the last quarter. Harbor Capital Advisors Inc. bought a new stake in shares of Sabra Health Care REIT during the third quarter valued at approximately $78,000. Finally, International Assets Investment Management LLC increased its holdings in shares of Sabra Health Care REIT by 1,761.0% during the third quarter. International Assets Investment Management LLC now owns 6,104 shares of the real estate investment trust’s stock valued at $114,000 after acquiring an additional 5,776 shares in the last quarter. 99.40% of the stock is currently owned by institutional investors.

Sabra Health Care REIT Stock Up 0.6 %

Shares of NASDAQ:SBRA opened at $18.52 on Tuesday. The stock has a market cap of $4.38 billion, a price-to-earnings ratio of 45.17, a PEG ratio of 2.31 and a beta of 1.25. The company has a quick ratio of 4.16, a current ratio of 4.16 and a debt-to-equity ratio of 0.90. Sabra Health Care REIT, Inc. has a 12-month low of $12.83 and a 12-month high of $20.03. The business’s 50 day moving average is $18.63 and its 200 day moving average is $16.73.

Sabra Health Care REIT (NASDAQ:SBRA) last posted its quarterly earnings data on Thursday, October 31st. The real estate investment trust reported $0.13 earnings per share for the quarter, missing the consensus estimate of $0.35 by ($0.22). Sabra Health Care REIT had a return on equity of 3.51% and a net margin of 14.20%. The business had revenue of $178.00 million during the quarter, compared to analysts’ expectations of $177.19 million. During the same period in the prior year, the firm posted $0.34 EPS. On average, sell-side analysts forecast that Sabra Health Care REIT, Inc. will post 1.39 earnings per share for the current fiscal year.

Sabra Health Care REIT Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 29th. Shareholders of record on Friday, November 15th will be given a $0.30 dividend. The ex-dividend date of this dividend is Friday, November 15th. This represents a $1.20 annualized dividend and a yield of 6.48%. Sabra Health Care REIT’s dividend payout ratio is currently 292.69%.

Wall Street Analyst Weigh In

Several equities research analysts have recently commented on SBRA shares. Truist Financial boosted their price objective on Sabra Health Care REIT from $16.00 to $18.00 and gave the company a “buy” rating in a report on Wednesday, September 4th. Wells Fargo & Company upgraded Sabra Health Care REIT from an “equal weight” rating to an “overweight” rating and boosted their price objective for the company from $16.00 to $20.00 in a report on Tuesday, October 1st. Scotiabank boosted their price objective on Sabra Health Care REIT from $17.00 to $18.00 and gave the company a “sector perform” rating in a report on Friday, October 11th. Finally, Citigroup raised Sabra Health Care REIT from a “neutral” rating to a “buy” rating and lifted their target price for the company from $17.00 to $20.00 in a research report on Friday, September 13th. One equities research analyst has rated the stock with a hold rating and six have given a buy rating to the company’s stock. According to MarketBeat, Sabra Health Care REIT presently has a consensus rating of “Moderate Buy” and an average target price of $18.71.

Sabra Health Care REIT Company Profile

As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities (Senior Housing – Leased), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing – Managed), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures.